日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization, Preconditioning, Safety, and Other Issues of MSC-Derived EVs and Secretome

间充质干细胞来源的细胞外囊泡和分泌组的特性、预处理、安全性及其他问题

Alpeeva, Elena V; Ryabchenko, Anfisa S; Vorotelyak, Ekaterina A

Inhibition of Proteasome LMP2 Activity Suppresses Chil3 Expression in Mouse Colon Adenocarcinoma Tissue and Restrains Tumor Growth.

抑制蛋白酶体LMP2活性可抑制小鼠结肠腺癌组织中Chil3的表达并抑制肿瘤生长

Astakhova Tatiana M, Karpov Nikita S, Dashenkova Nataliya O, Alpeeva Elena V, Nesterchuk Mikhail V, Akopov Sergey B, Mikaelyan Arsen S, Ryabchenko Anfisa S, Erokhov Pavel A, Sharova Natalia P

Using Small Molecules to Reprogram RPE Cells in Regenerative Medicine for Degenerative Eye Disease

利用小分子对视网膜色素上皮细胞进行重编程,用于再生医学治疗退行性眼病

Rzhanova, Lyubov A; Alpeeva, Elena V; Aleksandrova, Maria A

Review of hTERT-Immortalized Cells: How to Assess Immortality and Confirm Identity

hTERT永生化细胞的评估:如何评估永生性并确认其身份

Shitova, Maria; Alpeeva, Elena; Vorotelyak, Ekaterina

Global Biobank Meta-analysis Initiative: How can global health benefit by its use?

全球生物样本库荟萃分析计划:如何利用该计划造福全球健康?

Alpeeva, Elena V; Sharov, Konstantin S

Russian Biodiversity Collections: A Professional Opinion Survey

俄罗斯生物多样性收藏:一项专业意见调查

Alpeeva, Elena V; Sharova, Natalia P; Sharov, Konstantin S; Vorotelyak, Ekaterina A

Alveologenesis: What Governs Secondary Septa Formation

肺泡发生:次级隔膜形成的控制因素

Rippa, Alexandra L; Alpeeva, Elena V; Vasiliev, Andrey V; Vorotelyak, Ekaterina A

hTERT-Driven Immortalization of RDEB Fibroblast and Keratinocyte Cell Lines Followed by Cre-Mediated Transgene Elimination

hTERT 驱动的 RDEB 成纤维细胞和角质形成细胞系永生化,随后通过 Cre 介导的转基因消除

Nadezhda A Evtushenko, Arkadii K Beilin, Erdem B Dashinimaev, Rustam H Ziganshin, Anastasiya V Kosykh, Maxim M Perfilov, Alexandra L Rippa, Elena V Alpeeva, Andrey V Vasiliev, Ekaterina A Vorotelyak, Nadya G Gurskaya

Almost 40 Years of Tissue Engineering in Russia: Where Are We Now?

俄罗斯组织工程近40年:我们现在处于什么阶段?

Alpeeva, Elena; Sukhanov, Yury; Vorotelyak, Ekaterina